| Cheplapharm Schweiz GmbH - Sequase 25 mg, Filmtabletten | | 62331 | | 01 | | Sequase 25 mg | | Filmtabletten | | N05AH04 | | Quetiapin | | 01.09.2011 | | |
| | Composition | | quetiapinum 25 mg ut quetiapini fumaras, povidonum K 30, calcii hydrogenophosphas dihydricus, cellulosum microcristallinum, lactosum monohydricum 19 mg, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 400, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto corresp. natrium max. 0.294 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Quetiapine | 25 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Quetiapine | 25 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Rubrum) | | | | Calcium Hydrogenophosphate Dihydrate | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 19 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 60 Comprimé(s) | 17.35 | 35.25 | B | LS | Non |
|
|
